[HTML][HTML] Breast cancer: miRNAs monitoring chemoresistance and systemic therapy

S Singh, H Saini, A Sharma, S Gupta… - Frontiers in …, 2023 - frontiersin.org
With a high mortality rate that accounts for millions of cancer-related deaths each year,
breast cancer is the second most common malignancy in women. Chemotherapy has …

Cross-roads to drug resistance and metastasis in breast cancer: miRNAs regulatory function and biomarker capability

N Naser Al Deen, F Nassar, R Nasr… - Breast Cancer Metastasis …, 2019 - Springer
Breast cancer and specifically metastatic breast cancer (mBC) constitutes a major health
burden worldwide with the highest number of cancer-related mortality among women across …

MicroRNAs in breast cancer: one More Turn in Regulation

PE Asensio, ET Martin, BP Merlo… - Current drug …, 2016 - ingentaconnect.com
MicroRNAs (miRNAs) are small non-coding RNA molecules that critically regulate the
expression of genes. MiRNAs are involved in physiological cellular processes; however …

MicroRNAs and drug resistance of breast cancer: basic evidence and clinical applications

W Tian, J Chen, H He, Y Deng - Clinical and Translational Oncology, 2013 - Springer
Breast cancer is the most common malignancy and leading cause of cancer mortality in
women. Drug resistance is a major obstacle in systemic therapy of breast cancer, which …

MicroRNAs in breast cancer therapy

J Tang, A Ahmad, FH Sarkar - Current pharmaceutical design, 2014 - ingentaconnect.com
Breast cancer is one of the most common type of cancers as well as a principal cause of
cancer-related deaths in women worldwide. Although research has provided a better …

The role of microRNAs in the chemoresistance of breast cancer

J Wang, M Yang, Y Li, B Han - Drug development research, 2015 - Wiley Online Library
ABSTRACT Preclinical Research Breast cancer is the most prevalent malignancy in women
with more than 1.3 million new cases every year worldwide. Chemotherapy is a critical …

miRNAs in breast cancer: ready for real time?

J Krell, AE Frampton, J Jacob, L Castellano… - …, 2012 - Future Medicine
Over the past decade, major advances in our comprehension of breast cancer biology have
led to improved diagnostic and prognostic techniques and the development of novel …

Therapeutic delivery of tumor suppressor miRNAs for breast cancer treatment

SS Shinde, S Ahmed, JA Malik, U Hani, A Khanam… - Biology, 2023 - mdpi.com
Simple Summary The most frequent cancer in women is breast cancer (BC), which presents
a significant risk to their good health. Over the past few decades, several factors have …

Clinical theragnostic relationship between drug-resistance specific miRNA expressions, chemotherapeutic resistance, and sensitivity in breast cancer: a systematic …

R Jayaraj, MR Madhav, SG Nayagam, A Kar… - Cells, 2019 - mdpi.com
Awareness of breast cancer has been increasing due to early detection, but the advanced
disease has limited treatment options. There has been growing evidence on the role of …

Role of microRNA deregulation in breast cancer cell chemoresistance and stemness

TA Tekiner, H Basaga - Current medicinal chemistry, 2013 - ingentaconnect.com
Studies with breast cancer cells, showed that microRNAs (miRNAs) act as regulators of
signaling pathways playing a key role in tumor progression and being targeted in …